Achkar T, Tarhini AA (2017) The use of immunotherapy in the treatment of melanoma. J Hematol Oncol 10(1):88. https://doi.org/10.1186/s13045-017-0458-3
Article CAS PubMed PubMed Central Google Scholar
Ahn J, Xia T, Rabasa Capote A, Betancourt D, Barber GN (2018) Extrinsic phagocyte-dependent STING signaling dictates the immunogenicity of dying cells. Cancer Cell 33(5):862-873 e865. https://doi.org/10.1016/j.ccell.2018.03.027
Article CAS PubMed PubMed Central Google Scholar
Barker CA, Kim SK, Budhu S, Matsoukas K, Daniyan AF, D’Angelo SP (2018) Cytokine release syndrome after radiation therapy: case report and review of the literature. J Immunother Cancer 6(1):1. https://doi.org/10.1186/s40425-017-0311-9
Article PubMed PubMed Central Google Scholar
Cai L, Du X, Zhang C, Yu S, Liu L, Zhao J et al (2021) Robust immune response stimulated by in situ injection of CpG/alphaOX40/cGAMP in alphaPD-1-resistant malignancy. Cancer Immunol Immunother. https://doi.org/10.1007/s00262-021-03095-z
Article PubMed PubMed Central Google Scholar
Chatenoud L, Ferran C, Bach JF (1991) The anti-CD3-induced syndrome: a consequence of massive in vivo cell activation. Curr Top Microbiol Immunol 174:121–134. https://doi.org/10.1007/978-3-642-50998-8_9
Article CAS PubMed Google Scholar
Chen J, Zhong Y, Liu Y, Tang C, Zhang Y, Wei B et al (2020) Parenteral immunization with a cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) adjuvanted Helicobacter pylori vaccine induces protective immunity against H. pylori infection in mice. Hum Vaccin Immunother 16(11):2849–2854. https://doi.org/10.1080/21645515.2020.1744364
Article CAS PubMed PubMed Central Google Scholar
Chiang CL, Benencia F, Coukos G (2010) Whole tumor antigen vaccines. Semin Immunol 22(3):132–143. https://doi.org/10.1016/j.smim.2010.02.004
Article CAS PubMed PubMed Central Google Scholar
Cicchelero L, de Rooster H, Sanders NN (2014) Various ways to improve whole cancer cell vaccines. Expert Rev Vaccines 13(6):721–735. https://doi.org/10.1586/14760584.2014.911093
Article CAS PubMed Google Scholar
Conniot J, Scomparin A, Peres C, Yeini E, Pozzi S, Matos AI et al (2019) Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators. Nat Nanotechnol 14(9):891–901. https://doi.org/10.1038/s41565-019-0512-0
Article CAS PubMed Google Scholar
Del Bello A, Zakaroff AG, Meyer N, Delas A, Faguer S, Kamar N et al (2021) Cytokine storm induced by a PD1 inhibitor in a renal transplant patient. Am J Transplant 21(7):2616–2618. https://doi.org/10.1111/ajt.16589
Dikov MM, Oyama T, Cheng P, Takahashi T, Takahashi K, Sepetavec T et al (2001) Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells. Cancer Res 61(5):2015–2021
Dorostkar F, Arashkia A, Roohvand F, Shoja Z, Navari M, Shirazi MA, M., et al (2021) Co-administration of 2’3’-cGAMP STING activator and CpG-C adjuvants with a mutated form of HPV 16 E7 protein leads to tumor growth inhibition in the mouse model. Infect Agent Cancer 16(1):7. https://doi.org/10.1186/s13027-021-00346-7
Article CAS PubMed PubMed Central Google Scholar
Fabian KP, Padget MR, Fujii R, Schlom J, Hodge JW (2021) Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve. J Immunother Cancer. https://doi.org/10.1136/jitc-2020-001691
Article PubMed PubMed Central Google Scholar
Fajgenbaum DC, June CH (2020) Cytokine Storm. N Engl J Med 383(23):2255–2273. https://doi.org/10.1056/NEJMra2026131
Article CAS PubMed PubMed Central Google Scholar
Freyer CW, Porter DL (2020) Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies. J Allergy Clin Immunol 146(5):940–948. https://doi.org/10.1016/j.jaci.2020.07.025
Article CAS PubMed Google Scholar
Galluzzi L, Buque A, Kepp O, Zitvogel L, Kroemer G (2017) Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol 17(2):97–111. https://doi.org/10.1038/nri.2016.107
Article CAS PubMed Google Scholar
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB et al (2020) Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J Immunother Cancer. https://doi.org/10.1136/jitc-2019-000337
Article PubMed PubMed Central Google Scholar
Hebb JPO, Mosley AR, Vences-Catalan F, Rajasekaran N, Rosen A, Ellmark P et al (2018) Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression. Cancer Immunol Immunother 67(1):47–60. https://doi.org/10.1007/s00262-017-2059-y
Article CAS PubMed Google Scholar
Iho S, Maeyama J, Suzuki F (2015) CpG oligodeoxynucleotides as mucosal adjuvants. Hum Vaccin Immunother 11(3):755–760. https://doi.org/10.1080/21645515.2014.1004033
Article PubMed PubMed Central Google Scholar
Ishikawa H, Barber GN (2008) STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455(7213):674–678. https://doi.org/10.1038/nature07317
Article CAS PubMed PubMed Central Google Scholar
Ito H, Kanbe A, Hara A, Ishikawa T (2019) Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand. Virology 531:233–239. https://doi.org/10.1016/j.virol.2019.03.013
Article CAS PubMed Google Scholar
Jiang M, Chen P, Wang L, Li W, Chen B, Liu Y et al (2020) cGAS-STING, an important pathway in cancer immunotherapy. J Hematol Oncol 13(1):81. https://doi.org/10.1186/s13045-020-00916-z
Article CAS PubMed PubMed Central Google Scholar
Kawarada Y, Ganss R, Garbi N, Sacher T, Arnold B, Hämmerling GJ (2001) NK- and CD8+ T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides. J Immunol 167(9):5247–5253. https://doi.org/10.4049/jimmunol.167.9.5247
Article CAS PubMed Google Scholar
Keenan BP, Jaffee EM (2012) Whole cell vaccines—past progress and future strategies. Semin Oncol 39(3):276–286. https://doi.org/10.1053/j.seminoncol.2012.02.007
Article CAS PubMed PubMed Central Google Scholar
Kroemer G, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51–72. https://doi.org/10.1146/annurev-immunol-032712-100008
Article CAS PubMed Google Scholar
Kumai T, Lee S, Cho HI, Sultan H, Kobayashi H, Harabuchi Y et al (2017) Optimization of peptide vaccines to induce robust antitumor CD4 T-cell responses. Cancer Immunol Res 5(1):72–83. https://doi.org/10.1158/2326-6066.CIR-16-0194
Article CAS PubMed Google Scholar
Kunikata N, Sano K, Honda M, Ishii K, Matsunaga J, Okuyama R et al (2004) Peritumoral CpG oligodeoxynucleotide treatment inhibits tumor growth and metastasis of B16F10 melanoma cells. J Invest Dermatol 123(2):395–402. https://doi.org/10.1111/j.0022-202X.2004.23233.x
Article CAS PubMed Google Scholar
Li J, Li J, Aipire A, Luo J, Yuan P, Zhang F (2016a) The combination of Pleurotus ferulae water extract and CpG-ODN enhances the immune responses and antitumor efficacy of HPV peptides pulsed dendritic cell-based vaccine. Vaccine 34(31):3568–3575. https://doi.org/10.1016/j.vaccine.2016.05.022
Article CAS PubMed Google Scholar
Li T, Cheng H, Yuan H, Xu Q, Shu C, Zhang Y et al (2016b) Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response. Sci Rep 6:19049. https://doi.org/10.1038/srep19049
Article CAS PubMed PubMed Central Google Scholar
Linch SN, Kasiewicz MJ, McNamara MJ, Hilgart-Martiszus IF, Farhad M, Redmond WL (2016) Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice. Proc Natl Acad Sci U S A 113(3):E319-327. https://doi.org/10.1073/pnas.1510518113
Article CAS PubMed PubMed Central Google Scholar
Liu Y, Cao X (2016) Immunosuppressive cells in tumor immune escape and metastasis. J Mol Med (berl) 94(5):509–522. https://doi.org/10.1007/s00109-015-1376-x
Loercher AE, Nash MA, Kavanagh JJ, Platsoucas CD, Freedman RS (1999) Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J Immunol 163(11):6251–6260
Lonsdorf AS, Kuekrek H, Stern BV, Boehm BO, Lehmann PV, Tary-Lehmann M (2003) Intratumor CpG-oligodeoxynucleotide injection induces protective antitumor T cell immunity. J Immunol 171(8):3941–3946. https://doi.org/10.4049/jimmunol.171.8.3941
Article CAS PubMed Google Scholar
Makkouk A, Joshi VB, Lemke CD, Wongrakpanich A, Olivier AK, Blackwell SE et al (2015) Three steps to breaking immune tolerance to lymphoma: a microparticle approach. Cancer Immunol Res 3(4):389–398. https://doi.org/10.1158/2326-6066.CIR-14-0173
留言 (0)